• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
AVE

AVECHO BIOTECHNOLOGY LIMITED - Announcements

0.00% ! 0.6¢
Market Cap $19.04M  !

Avecho Biotechnology Limited is an Australia-based biopharmaceutical company. The Company... Avecho Biotechnology Limited is an Australia-based biopharmaceutical company. The Company develops and commercializes human and animal health products using its drug delivery system called Tocopheryl Phosphate Mixture (TPM). TPM is derived from vitamin E using patented processes. The Company's segments include Production and Human Health. The Production segment manufactures and sells TPM and Vital ET for use in drug delivery and cosmetic formulations. The Human Health portfolio covers delivery of pharmaceutical products through gels, injectables and patches, including conduct of research and development activities. The Company's products pipeline includes Weaner Pig Starter TPM Premix, Poultry TPM Premix, Dairy TPM Premix, Daptomycin, Propofol and Veterinary Applications. The Company is also developing TPM to enhance feed efficiency and the health of livestock. Its TPM products are commercialized under license: Voveran TPM Gel, Instanac TPM Gel, Vital ET, and Ashland TPM. More

Announcements



AVE September 2022 Quarterly Activities Report & Appendix 4CPRICE SENSITIVE28/10/22 download Created with Sketch. 310.85KB
AVE Increased CBD absorption in dogs vs commercial comparatorPRICE SENSITIVE19/09/22 download Created with Sketch. 85.86KB
AVE Application for quotation of securities - AVE01/09/22 download Created with Sketch. 24.69KB
AVE Section 708A Cleansing Statement01/09/22 download Created with Sketch. 92.39KB
AVE Appendix 4D and Half-year Financial ReportPRICE SENSITIVE29/08/22 download Created with Sketch. 598.88KB
AVE June 2022 Quarterly Activities Report & Appendix 4CPRICE SENSITIVE29/07/22 download Created with Sketch. 176.18KB
AVE Security Class Reinstatement to Quotation- AVEOPRICE SENSITIVE14/07/22 download Created with Sketch. 86.31KB
AVE Update on Listed Options and Federal Court ApplicationPRICE SENSITIVE14/07/22 download Created with Sketch. 239.84KB
AVE Suspension from Official Quotation - AVEOPRICE SENSITIVE08/06/22 download Created with Sketch. 148.32KB
AVE Adoption of New Constitution30/05/22 download Created with Sketch. 1.24MB
AVE 2022 Annual General Meeting Results30/05/22 download Created with Sketch. 358.14KB
AVE Chair's Address and CEO Presentation30/05/22 download Created with Sketch. 1.64MB
AVE Receipt of R&D Tax IncentivePRICE SENSITIVE03/05/22 download Created with Sketch. 92.21KB
AVE March 2022 Quarterly Activities Report & Appendix 4CPRICE SENSITIVE29/04/22 download Created with Sketch. 142.17KB
AVE Notice of Annual General Meeting/Proxy Form28/04/22 download Created with Sketch. 509.41KB
AVE Positive results from AVE's topical CBD pain studyPRICE SENSITIVE29/03/22 download Created with Sketch. 274.68KB
AVE Dosing begins in topical CBD pain studyPRICE SENSITIVE01/03/22 download Created with Sketch. 93.08KB
AVE Appendix 4G and Corporate Governance Statement28/02/22 download Created with Sketch. 565.04KB
AVE Appendix 4E and Annual Report 31 December 2021PRICE SENSITIVE28/02/22 download Created with Sketch. 1.38MB
AVE AVE license agreement for US recreational cannabis marketPRICE SENSITIVE02/02/22 download Created with Sketch. 203.08KB
AVE December 2021 Quarterly Activities Report & Appendix 4CPRICE SENSITIVE31/01/22 download Created with Sketch. 294.5KB
AVE Application for quotation of securities - AVE10/01/22 download Created with Sketch. 27.42KB
AVE Section 708A Cleansing Statement10/01/22 download Created with Sketch. 171.34KB
AVE AVE Licenses CBD Soft-Gel to Medterra Pharma for ArthritisPRICE SENSITIVE20/12/21 download Created with Sketch. 214.39KB
AVE Positive results from Avecho's Phase I trial of CBD soft-gelPRICE SENSITIVE08/12/21 download Created with Sketch. 122.89KB
AVE September 2021 Quarterly Activities Report & Appendix 4CPRICE SENSITIVE29/10/21 download Created with Sketch. 754.33KB
AVE Topical CBD pain study with Lambert Initiative approvedPRICE SENSITIVE21/10/21 download Created with Sketch. 151.27KB
AVE Dosing begins in Phase I PK trial testing CBD soft-gelPRICE SENSITIVE04/10/21 download Created with Sketch. 92.31KB
AVE Phase I clinical trial testing CBD product-enrolment beginsPRICE SENSITIVE15/09/21 download Created with Sketch. 72.69KB
AVE Change of Director's Interest Notice10/09/21 download Created with Sketch. 237.98KB
AVE Notification of cessation of securities - AVE10/09/21 download Created with Sketch. 21.56KB
AVE Appendix 4D and Half-year Financial ReportPRICE SENSITIVE24/08/21 download Created with Sketch. 921.78KB
AVE June 2021 Quarterly Activities Report & Appendix 4CPRICE SENSITIVE27/07/21 download Created with Sketch. 337.74KB
AVE Application for quotation of securities - AVE01/07/21 download Created with Sketch. 24.99KB
AVE Section 708A Cleansing Statement01/07/21 download Created with Sketch. 58.51KB
AVE Avecho to Present New CBD Data at GCI Virtual SummitPRICE SENSITIVE08/06/21 download Created with Sketch. 1.86MB
AVE Change of Director's Interest Notice x331/05/21 download Created with Sketch. 416.47KB
AVE Appendix 3G31/05/21 download Created with Sketch. 238.41KB
AVE Final Director's Interest Notice31/05/21 download Created with Sketch. 220.09KB
AVE 2021 Annual General Meeting Results31/05/21 download Created with Sketch. 70.04KB
AVE Chair's Address and CEO PresentationPRICE SENSITIVE31/05/21 download Created with Sketch. 884.66KB
AVE AB Vista to explore new TPM applications for Animal HealthPRICE SENSITIVE31/05/21 download Created with Sketch. 101.54KB
AVE Changes to AGM attendance protocols26/05/21 download Created with Sketch. 373.79KB
AVE TGA meeting for CBD soft-gel targeting insomniaPRICE SENSITIVE26/05/21 download Created with Sketch. 101.62KB
AVE Avecho completes pharmaceutical CBD soft-gel productPRICE SENSITIVE21/05/21 download Created with Sketch. 190.37KB
AVE Resignation of Director & Withdrawal of AGM Resolution04/05/21 download Created with Sketch. 99.66KB
AVE Notice of Annual General Meeting/Proxy Form30/04/21 download Created with Sketch. 654.93KB
AVE March 2021 Quarterly Activities Report & Appendix 4CPRICE SENSITIVE28/04/21 download Created with Sketch. 396.86KB
AVE Avecho receives ethics approval for CBD human trialPRICE SENSITIVE13/04/21 download Created with Sketch. 78KB
AVE Appendix 4G and Corporate Governance Statement26/03/21 download Created with Sketch. 770.34KB
AVE Annual Report - 31 December 202026/03/21 download Created with Sketch. 777.8KB
AVE Appendix 4E - Preliminary Final ReportPRICE SENSITIVE26/02/21 download Created with Sketch. 518.98KB
AVE Appendix 2A - Options17/02/21 download Created with Sketch. 386.67KB
AVE S708A Cleansing Notice and Appendix 2A17/02/21 download Created with Sketch. 411.3KB
AVE Update - Proposed issue of Securities - AVE16/02/21 download Created with Sketch. 33.78KB
AVE Proposed issue of Securities - AVE10/02/21 download Created with Sketch. 33.88KB
AVE AVE receives firm commitment to raise $5.06 via placementPRICE SENSITIVE10/02/21 download Created with Sketch. 112.33KB
AVE Trading HaltPRICE SENSITIVE08/02/21 download Created with Sketch. 217.82KB
AVE December 2020 Quarterly Activities Report & Appendix 4CPRICE SENSITIVE29/01/21 download Created with Sketch. 325.7KB
AVE AVE begins Human Trial on CBD productPRICE SENSITIVE23/12/20 download Created with Sketch. 192.01KB
AVE Section 708A Cleansing Statement & Appendix 2A23/12/20 download Created with Sketch. 404.53KB
AVE Grant of Unlisted Options & Appendix 3G20/11/20 download Created with Sketch. 405.55KB
AVE Improved Propofol TPM Formulation Passes Toxicology StudyPRICE SENSITIVE04/11/20 download Created with Sketch. 77KB
AVE September 2020 Quarterly Activities Report & Appendix 4CPRICE SENSITIVE28/10/20 download Created with Sketch. 378.65KB
AVE Response to ASX Price QueryPRICE SENSITIVE26/10/20 download Created with Sketch. 783.85KB
AVE TPM Cannabinoid Development Program UpdatePRICE SENSITIVE19/10/20 download Created with Sketch. 123.5KB
AVE Receipt of R&D Tax IncentivePRICE SENSITIVE17/09/20 download Created with Sketch. 61.58KB
AVE Securities Trading Policy28/08/20 download Created with Sketch. 130.79KB
AVE Appendix 4D and Half-year Financial ReportPRICE SENSITIVE28/08/20 download Created with Sketch. 1.06MB
AVE Progress Update for TPM Cannabinoid Development ProgramPRICE SENSITIVE20/08/20 download Created with Sketch. 115.56KB
AVE Appendix 3G18/08/20 download Created with Sketch. 279.15KB
AVE June 2020 Quarterly Activities Report & Appendix 4CPRICE SENSITIVE28/07/20 download Created with Sketch. 326.06KB
AVE Response to ASX Price QueryPRICE SENSITIVE23/07/20 download Created with Sketch. 267.8KB
AVE 2020 Annual General Meeting Results13/07/20 download Created with Sketch. 94.03KB
AVE CEO Presentation (AGM)13/07/20 download Created with Sketch. 676.87KB
AVE Avecho Investor Update15/06/20 download Created with Sketch. 1.06MB
AVE Notice of Annual General Meeting/Proxy Form11/06/20 download Created with Sketch. 475.41KB
AVE Date of AGM and Closing Date for Nomination of Director18/05/20 download Created with Sketch. 61.31KB
AVE March 2020 Quarterly Activities Report & Appendix 4CPRICE SENSITIVE29/04/20 download Created with Sketch. 96.98KB
AVE Section 708A Cleansing Statement & Appendix 2A27/04/20 download Created with Sketch. 515.02KB
AVE Changes to Leadership TeamPRICE SENSITIVE27/04/20 download Created with Sketch. 127.58KB
AVE Medicinal cannabis supply agreement with Tasmanian AlkaloidsPRICE SENSITIVE27/04/20 download Created with Sketch. 141.67KB
AVE Avecho signs Term Sheet for Cannabinoid Supply with PurisysPRICE SENSITIVE14/04/20 download Created with Sketch. 73.99KB
AVE Chairman's Address09/04/20 download Created with Sketch. 197.94KB
AVE Deferral of Annual General Meeting25/03/20 download Created with Sketch. 114.77KB
AVE Date of AGM and Closing Date for Nomination of Director17/03/20 download Created with Sketch. 60.89KB
AVE Change of Director's Interest Notice02/03/20 download Created with Sketch. 293KB
AVE Lapse of Unlisted Options02/03/20 download Created with Sketch. 61.7KB
AVE Appendix 4G and Corporate Governance Statement02/03/20 download Created with Sketch. 423.09KB
AVE Appendix 4E and Annual Report 31 December 2019PRICE SENSITIVE02/03/20 download Created with Sketch. 1.43MB
AVE Appendix 4C - QuarterlyPRICE SENSITIVE23/01/20 download Created with Sketch. 215.18KB
AVE Initial Director's Interest Notice13/01/20 download Created with Sketch. 125.29KB
AVE Appointment of New Director13/01/20 download Created with Sketch. 55.85KB
AVE Injectable Portfolio Update - Products Differentiated by TPMPRICE SENSITIVE04/12/19 download Created with Sketch. 1.19MB
AVE Change in substantial holding22/10/19 download Created with Sketch. 1.88MB
AVE Terumo return rights to TPM/Propofol InjectablePRICE SENSITIVE17/10/19 download Created with Sketch. 63.87KB
AVE Appendix 4C - QuarterlyPRICE SENSITIVE10/10/19 download Created with Sketch. 175.98KB
AVE Securities Trading Policy30/08/19 download Created with Sketch. 164.37KB
AVE Appendix 4D and Half-year Financial ReportPRICE SENSITIVE30/08/19 download Created with Sketch. 897.76KB
AVE Appendix 4C - QuarterlyPRICE SENSITIVE22/07/19 download Created with Sketch. 81.61KB
AVE September 2022 Quarterly Activities Report & Appendix 4C
28/10/22PRICE SENSITIVE download Created with Sketch. 310.85KB
AVE Increased CBD absorption in dogs vs commercial comparator
19/09/22PRICE SENSITIVE download Created with Sketch. 85.86KB
AVE Application for quotation of securities - AVE
01/09/22 download Created with Sketch. 24.69KB
AVE Section 708A Cleansing Statement
01/09/22 download Created with Sketch. 92.39KB
AVE Appendix 4D and Half-year Financial Report
29/08/22PRICE SENSITIVE download Created with Sketch. 598.88KB
AVE June 2022 Quarterly Activities Report & Appendix 4C
29/07/22PRICE SENSITIVE download Created with Sketch. 176.18KB
AVE Security Class Reinstatement to Quotation- AVEO
14/07/22PRICE SENSITIVE download Created with Sketch. 86.31KB
AVE Update on Listed Options and Federal Court Application
14/07/22PRICE SENSITIVE download Created with Sketch. 239.84KB
AVE Suspension from Official Quotation - AVEO
08/06/22PRICE SENSITIVE download Created with Sketch. 148.32KB
AVE Adoption of New Constitution
30/05/22 download Created with Sketch. 1.24MB
AVE 2022 Annual General Meeting Results
30/05/22 download Created with Sketch. 358.14KB
AVE Chair's Address and CEO Presentation
30/05/22 download Created with Sketch. 1.64MB
AVE Receipt of R&D Tax Incentive
03/05/22PRICE SENSITIVE download Created with Sketch. 92.21KB
AVE March 2022 Quarterly Activities Report & Appendix 4C
29/04/22PRICE SENSITIVE download Created with Sketch. 142.17KB
AVE Notice of Annual General Meeting/Proxy Form
28/04/22 download Created with Sketch. 509.41KB
AVE Positive results from AVE's topical CBD pain study
29/03/22PRICE SENSITIVE download Created with Sketch. 274.68KB
AVE Dosing begins in topical CBD pain study
01/03/22PRICE SENSITIVE download Created with Sketch. 93.08KB
AVE Appendix 4G and Corporate Governance Statement
28/02/22 download Created with Sketch. 565.04KB
AVE Appendix 4E and Annual Report 31 December 2021
28/02/22PRICE SENSITIVE download Created with Sketch. 1.38MB
AVE AVE license agreement for US recreational cannabis market
02/02/22PRICE SENSITIVE download Created with Sketch. 203.08KB
AVE December 2021 Quarterly Activities Report & Appendix 4C
31/01/22PRICE SENSITIVE download Created with Sketch. 294.5KB
AVE Application for quotation of securities - AVE
10/01/22 download Created with Sketch. 27.42KB
AVE Section 708A Cleansing Statement
10/01/22 download Created with Sketch. 171.34KB
AVE AVE Licenses CBD Soft-Gel to Medterra Pharma for Arthritis
20/12/21PRICE SENSITIVE download Created with Sketch. 214.39KB
AVE Positive results from Avecho's Phase I trial of CBD soft-gel
08/12/21PRICE SENSITIVE download Created with Sketch. 122.89KB
AVE September 2021 Quarterly Activities Report & Appendix 4C
29/10/21PRICE SENSITIVE download Created with Sketch. 754.33KB
AVE Topical CBD pain study with Lambert Initiative approved
21/10/21PRICE SENSITIVE download Created with Sketch. 151.27KB
AVE Dosing begins in Phase I PK trial testing CBD soft-gel
04/10/21PRICE SENSITIVE download Created with Sketch. 92.31KB
AVE Phase I clinical trial testing CBD product-enrolment begins
15/09/21PRICE SENSITIVE download Created with Sketch. 72.69KB
AVE Change of Director's Interest Notice
10/09/21 download Created with Sketch. 237.98KB
AVE Notification of cessation of securities - AVE
10/09/21 download Created with Sketch. 21.56KB
AVE Appendix 4D and Half-year Financial Report
24/08/21PRICE SENSITIVE download Created with Sketch. 921.78KB
AVE June 2021 Quarterly Activities Report & Appendix 4C
27/07/21PRICE SENSITIVE download Created with Sketch. 337.74KB
AVE Application for quotation of securities - AVE
01/07/21 download Created with Sketch. 24.99KB
AVE Section 708A Cleansing Statement
01/07/21 download Created with Sketch. 58.51KB
AVE Avecho to Present New CBD Data at GCI Virtual Summit
08/06/21PRICE SENSITIVE download Created with Sketch. 1.86MB
AVE Change of Director's Interest Notice x3
31/05/21 download Created with Sketch. 416.47KB
AVE Appendix 3G
31/05/21 download Created with Sketch. 238.41KB
AVE Final Director's Interest Notice
31/05/21 download Created with Sketch. 220.09KB
AVE 2021 Annual General Meeting Results
31/05/21 download Created with Sketch. 70.04KB
AVE Chair's Address and CEO Presentation
31/05/21PRICE SENSITIVE download Created with Sketch. 884.66KB
AVE AB Vista to explore new TPM applications for Animal Health
31/05/21PRICE SENSITIVE download Created with Sketch. 101.54KB
AVE Changes to AGM attendance protocols
26/05/21 download Created with Sketch. 373.79KB
AVE TGA meeting for CBD soft-gel targeting insomnia
26/05/21PRICE SENSITIVE download Created with Sketch. 101.62KB
AVE Avecho completes pharmaceutical CBD soft-gel product
21/05/21PRICE SENSITIVE download Created with Sketch. 190.37KB
AVE Resignation of Director & Withdrawal of AGM Resolution
04/05/21 download Created with Sketch. 99.66KB
AVE Notice of Annual General Meeting/Proxy Form
30/04/21 download Created with Sketch. 654.93KB
AVE March 2021 Quarterly Activities Report & Appendix 4C
28/04/21PRICE SENSITIVE download Created with Sketch. 396.86KB
AVE Avecho receives ethics approval for CBD human trial
13/04/21PRICE SENSITIVE download Created with Sketch. 78KB
AVE Appendix 4G and Corporate Governance Statement
26/03/21 download Created with Sketch. 770.34KB
AVE Annual Report - 31 December 2020
26/03/21 download Created with Sketch. 777.8KB
AVE Appendix 4E - Preliminary Final Report
26/02/21PRICE SENSITIVE download Created with Sketch. 518.98KB
AVE Appendix 2A - Options
17/02/21 download Created with Sketch. 386.67KB
AVE S708A Cleansing Notice and Appendix 2A
17/02/21 download Created with Sketch. 411.3KB
AVE Update - Proposed issue of Securities - AVE
16/02/21 download Created with Sketch. 33.78KB
AVE Proposed issue of Securities - AVE
10/02/21 download Created with Sketch. 33.88KB
AVE AVE receives firm commitment to raise $5.06 via placement
10/02/21PRICE SENSITIVE download Created with Sketch. 112.33KB
AVE Trading Halt
08/02/21PRICE SENSITIVE download Created with Sketch. 217.82KB
AVE December 2020 Quarterly Activities Report & Appendix 4C
29/01/21PRICE SENSITIVE download Created with Sketch. 325.7KB
AVE AVE begins Human Trial on CBD product
23/12/20PRICE SENSITIVE download Created with Sketch. 192.01KB
AVE Section 708A Cleansing Statement & Appendix 2A
23/12/20 download Created with Sketch. 404.53KB
AVE Grant of Unlisted Options & Appendix 3G
20/11/20 download Created with Sketch. 405.55KB
AVE Improved Propofol TPM Formulation Passes Toxicology Study
04/11/20PRICE SENSITIVE download Created with Sketch. 77KB
AVE September 2020 Quarterly Activities Report & Appendix 4C
28/10/20PRICE SENSITIVE download Created with Sketch. 378.65KB
AVE Response to ASX Price Query
26/10/20PRICE SENSITIVE download Created with Sketch. 783.85KB
AVE TPM Cannabinoid Development Program Update
19/10/20PRICE SENSITIVE download Created with Sketch. 123.5KB
AVE Receipt of R&D Tax Incentive
17/09/20PRICE SENSITIVE download Created with Sketch. 61.58KB
AVE Securities Trading Policy
28/08/20 download Created with Sketch. 130.79KB
AVE Appendix 4D and Half-year Financial Report
28/08/20PRICE SENSITIVE download Created with Sketch. 1.06MB
AVE Progress Update for TPM Cannabinoid Development Program
20/08/20PRICE SENSITIVE download Created with Sketch. 115.56KB
AVE Appendix 3G
18/08/20 download Created with Sketch. 279.15KB
AVE June 2020 Quarterly Activities Report & Appendix 4C
28/07/20PRICE SENSITIVE download Created with Sketch. 326.06KB
AVE Response to ASX Price Query
23/07/20PRICE SENSITIVE download Created with Sketch. 267.8KB
AVE 2020 Annual General Meeting Results
13/07/20 download Created with Sketch. 94.03KB
AVE CEO Presentation (AGM)
13/07/20 download Created with Sketch. 676.87KB
AVE Avecho Investor Update
15/06/20 download Created with Sketch. 1.06MB
AVE Notice of Annual General Meeting/Proxy Form
11/06/20 download Created with Sketch. 475.41KB
AVE Date of AGM and Closing Date for Nomination of Director
18/05/20 download Created with Sketch. 61.31KB
AVE March 2020 Quarterly Activities Report & Appendix 4C
29/04/20PRICE SENSITIVE download Created with Sketch. 96.98KB
AVE Section 708A Cleansing Statement & Appendix 2A
27/04/20 download Created with Sketch. 515.02KB
AVE Changes to Leadership Team
27/04/20PRICE SENSITIVE download Created with Sketch. 127.58KB
AVE Medicinal cannabis supply agreement with Tasmanian Alkaloids
27/04/20PRICE SENSITIVE download Created with Sketch. 141.67KB
AVE Avecho signs Term Sheet for Cannabinoid Supply with Purisys
14/04/20PRICE SENSITIVE download Created with Sketch. 73.99KB
AVE Chairman's Address
09/04/20 download Created with Sketch. 197.94KB
AVE Deferral of Annual General Meeting
25/03/20 download Created with Sketch. 114.77KB
AVE Date of AGM and Closing Date for Nomination of Director
17/03/20 download Created with Sketch. 60.89KB
AVE Change of Director's Interest Notice
02/03/20 download Created with Sketch. 293KB
AVE Lapse of Unlisted Options
02/03/20 download Created with Sketch. 61.7KB
AVE Appendix 4G and Corporate Governance Statement
02/03/20 download Created with Sketch. 423.09KB
AVE Appendix 4E and Annual Report 31 December 2019
02/03/20PRICE SENSITIVE download Created with Sketch. 1.43MB
AVE Appendix 4C - Quarterly
23/01/20PRICE SENSITIVE download Created with Sketch. 215.18KB
AVE Initial Director's Interest Notice
13/01/20 download Created with Sketch. 125.29KB
AVE Appointment of New Director
13/01/20 download Created with Sketch. 55.85KB
AVE Injectable Portfolio Update - Products Differentiated by TPM
04/12/19PRICE SENSITIVE download Created with Sketch. 1.19MB
AVE Change in substantial holding
22/10/19 download Created with Sketch. 1.88MB
AVE Terumo return rights to TPM/Propofol Injectable
17/10/19PRICE SENSITIVE download Created with Sketch. 63.87KB
AVE Appendix 4C - Quarterly
10/10/19PRICE SENSITIVE download Created with Sketch. 175.98KB
AVE Securities Trading Policy
30/08/19 download Created with Sketch. 164.37KB
AVE Appendix 4D and Half-year Financial Report
30/08/19PRICE SENSITIVE download Created with Sketch. 897.76KB
AVE Appendix 4C - Quarterly
22/07/19PRICE SENSITIVE download Created with Sketch. 81.61KB
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
0.6¢
Change
0.000(0.00%)
Mkt cap ! $19.04M
Open High Low Value Volume
0.7¢ 0.7¢ 0.6¢ $344 55.81K

Buyers (Bids)

No. Vol. Price($)
21 10913781 0.6¢
 

Sellers (Offers)

Price($) Vol. No.
0.7¢ 516922 2
View Market Depth
Last trade - 16.10pm 12/09/2025 (20 minute delay) ?
AVE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.